Cargando…
Correction to: Identifying Patients for Self-Administration of Omalizumab
Autores principales: | Murphy, Kevin R., Winders, Tonya, Smith, Brandy, Millette, Lauren, Chipps, Bradley E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898316/ https://www.ncbi.nlm.nih.gov/pubmed/36401056 http://dx.doi.org/10.1007/s12325-022-02373-1 |
Ejemplares similares
-
Identifying Patients for Self-Administration of Omalizumab
por: Murphy, Kevin R., et al.
Publicado: (2022) -
Omalizumab and quality of life in nasal polyps: A post hoc analysis
por: Han, Joseph K., et al.
Publicado: (2022) -
Safety Evaluation of an Expedited Omalizumab Home Self-Administration Pathway
por: Hussain, Zobia, et al.
Publicado: (2021) -
The impact of home treatment and self-administration of omalizumab on chronic urticaria
por: Wiuff, Anne Christine, et al.
Publicado: (2022) -
Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics
por: Liu, Mark C., et al.
Publicado: (2021)